Abstract
The scaling up of data in clinical pharmacology and the merger of systems biology and pharmacology has led to the emergence of a new discipline of Quantitative and Systems Pharmacology (QSP). This new research direction might significantly advance the discovery, development, and clinical use of therapeutic drugs. Research communities from computational biology, systems biology, and biological engineering—working collaboratively with pharmacologists, geneticists, biochemists, and analytical chemists—are creating and modeling large data on drug effects that is transforming our understanding of how these drugs work at a network level. In this review, we highlight developments in a new and rapidly growing field—pharmacometabolomics—in which large biochemical data‐capturing effects of genome, gut microbiome, and environment exposures is revealing information about metabotypes and treatment outcomes, and creating metabolic signatures as new potential biomarkers. Pharmacometabolomics informs and complements pharmacogenomics and together they provide building blocks for QSP.
Keywords
Systems pharmacologyPharmacogenomicsSystems biologyComputational biologyPrecision medicineClinical pharmacologySystems medicineMetabolomicsDrug discoveryData scienceComputer scienceBiologyBioinformaticsPharmacologyDrugGenetics
Affiliated Institutions
Related Publications
DrugBank 3.0: a comprehensive resource for 'Omics' research on drugs
DrugBank (http://www.drugbank.ca) is a richly annotated database of drug and drug target information. It contains extensive data on the nomenclature, ontology, chemistry, struct...
DrugBank 5.0: a major update to the DrugBank database for 2018
DrugBank (www.drugbank.ca) is a web-enabled database containing comprehensive molecular information about drugs, their mechanisms, their interactions and their targets. First de...
Precision medicine: from pharmacogenomics to pharmacoproteomics
Disease progression and drug response may vary significantly from patient to patient. Fortunately, the rapid development of high-throughput 'omics' technologies has allowed for ...
DrugBank: a knowledgebase for drugs, drug actions and drug targets
DrugBank is a richly annotated resource that combines detailed drug data with comprehensive drug target and drug action information. Since its first release in 2006, DrugBank ha...
Pharmacogenomics: a systems approach
Abstract Pharmacogenetics and pharmacogenomics involve the study of the role of inheritance in individual variation in drug response, a phenotype that varies from potentially li...
Publication Info
- Year
- 2015
- Type
- review
- Volume
- 98
- Issue
- 1
- Pages
- 71-75
- Citations
- 159
- Access
- Closed
External Links
Social Impact
Altmetric
PlumX Metrics
Social media, news, blog, policy document mentions
Citation Metrics
159
OpenAlex
Cite This
Rima Kaddurah‐Daouk,
Richard M. Weinshilboum
(2015).
Metabolomic Signatures for Drug Response Phenotypes: Pharmacometabolomics Enables Precision Medicine.
Clinical Pharmacology & Therapeutics
, 98
(1)
, 71-75.
https://doi.org/10.1002/cpt.134
Identifiers
- DOI
- 10.1002/cpt.134